In 2018, the global defibrillator market was worth about USD 9.8 billion and is expected to grow to over USD 21.1 billion by 2032, with a steady annual growth rate of 5.7%. North America led the market in 2018, holding nearly 45% of the total market share.
The defibrillator market is witnessing significant growth globally, driven by the increasing prevalence of cardiovascular diseases and the rising incidence of sudden cardiac arrests. Defibrillators, which deliver therapeutic shocks to restore normal heart rhythm, are becoming essential components of emergency medical care. Technological advancements, such as the development of automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs), and wearable devices, are enhancing ease of use and expanding their application across various healthcare settings. Moreover, growing awareness about cardiac health, supportive government initiatives, and improved access to emergency medical services are further contributing to the market's expansion. As healthcare systems continue to prioritize early intervention and life-saving technologies, the defibrillator market is expected to maintain a strong growth trajectory in the coming years.
Continue reading for more details:
https://www.fortunebusinessinsights.com/industry-reports/defibrillator-market-100950
Market Size & Forecast
The global defibrillator market was valued at over USD 9 billion in 2018 and is projected to exceed USD 21 billion by 2032.
The market is expected to grow at a steady CAGR of 5.7% over the forecast period from 2018 to 2032.
Rising cardiovascular disease prevalence, growing aging population, and technological advancements are key factors driving long-term market expansion.
Market Share
North America held the leading position in the global defibrillator market in 2018, capturing nearly 45% share. This dominance was fueled by high public and private installations, government mandates, and growing awareness of cardiac arrest response.
Among product segments, Implantable Cardioverter Defibrillators (ICDs) remained the largest contributor, particularly the CRT-D subtype, owing to their widespread use in developed healthcare systems and higher reimbursement coverage.
Key Country Highlights
Japan: Market growth is supported by increasing adoption of wearable defibrillators, proactive government measures for cardiac health, and focus on emergency response systems.
United States: High occurrence of sudden cardiac events, AED placement requirements in public spaces, and a shift toward advanced devices like subcutaneous ICDs contribute significantly to market leadership.
China: Ongoing healthcare infrastructure expansion and rising public education regarding cardiovascular emergencies are driving adoption of both external and implantable defibrillators.
Europe: Comprehensive training programs, favorable regulatory frameworks, and strong public health infrastructure are helping the region maintain a prominent position. Europe is expected to be the second-largest contributor to global revenue by the mid-2020s.
Market Segmentation
The defibrillator market is segmented by product type, including automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs), and wearable cardioverter defibrillators (WCDs).
Based on end-users, the market is divided into hospitals, pre-hospital care settings, public access markets, and home care settings.
The market can also be segmented by patient type, such as adult and pediatric patients.
By technology, the defibrillator market includes biphasic and monophasic defibrillation systems.
Distribution channels for the defibrillator market include direct sales, distributors, and online retail platforms.sss
List Of Companies Profiled In Defibrillator Market:
Asahi Kasei Corporation
Philips Healthcare
Defibtech, LLC.
Cardiac Science
Stryker
CU Medical System Inc.
Medtronic
Boston Scientific Corporation
Biotronik
LivaNova Plc
Abbott
Microport
Other prominent players
Market Growth:
The defibrillator market is experiencing steady growth due to rising incidences of sudden cardiac arrests and cardiovascular diseases worldwide.
Increasing awareness about the benefits of early defibrillation and expanding access to emergency medical services are key contributors to the growth of the defibrillator market.
Technological advancements, including the development of wearable and implantable defibrillators, are further accelerating market expansion.
Government initiatives and funding for public access defibrillation programs are creating additional opportunities for growth in the defibrillator market.
The growing elderly population and a rise in the number of high-risk patients are expected to continue driving demand in the defibrillator market through the forecast period.
Restraining Factors
High costs associated with advanced defibrillator devices and their maintenance limit adoption, especially in low-income regions.
Stringent regulatory approvals and delays in product launches can hamper the defibrillator market growth.
Limited awareness and training for the usage of defibrillators in remote and underdeveloped areas act as a barrier.
Risk of malfunction or device failure, especially in implantable devices, can hinder patient and physician confidence in the defibrillator market.
Reimbursement challenges and budget constraints in public healthcare systems may slow down procurement.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free)
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com